Anti-RRP7A monoclonal antibody

Pre-made anti-RRP7A monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to RRP7A/RRP7A products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2717-Ab-1/ GM-Tg-hg-IP2717-Ab-2Anti-Human RRP7A monoclonal antibodyHuman
GM-Tg-rg-IP2717-Ab-1/ GM-Tg-rg-IP2717-Ab-2Anti-Rat RRP7A monoclonal antibodyRat
GM-Tg-mg-IP2717-Ab-1/ GM-Tg-mg-IP2717-Ab-2Anti-Mouse RRP7A monoclonal antibodyMouse
GM-Tg-cynog-IP2717-Ab-1/ GM-Tg-cynog-IP2717-Ab-2Anti-Cynomolgus/ Rhesus macaque RRP7A monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2717-Ab-1/ GM-Tg-felg-IP2717-Ab-2Anti-Feline RRP7A monoclonal antibodyFeline
GM-Tg-cang-IP2717-Ab-1/ GM-Tg-cang-IP2717-Ab-2Anti-Canine RRP7A monoclonal antibodyCanine
GM-Tg-bovg-IP2717-Ab-1/ GM-Tg-bovg-IP2717-Ab-2Anti-Bovine RRP7A monoclonal antibodyBovine
GM-Tg-equg-IP2717-Ab-1/ GM-Tg-equg-IP2717-Ab-2Anti-Equine RRP7A monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2717-Ab-1/ GM-Tg-hg-IP2717-Ab-2; GM-Tg-rg-IP2717-Ab-1/ GM-Tg-rg-IP2717-Ab-2;
GM-Tg-mg-IP2717-Ab-1/ GM-Tg-mg-IP2717-Ab-2; GM-Tg-cynog-IP2717-Ab-1/ GM-Tg-cynog-IP2717-Ab-2;
GM-Tg-felg-IP2717-Ab-1/ GM-Tg-felg-IP2717-Ab-2; GM-Tg-cang-IP2717-Ab-1/ GM-Tg-cang-IP2717-Ab-2;
GM-Tg-bovg-IP2717-Ab-1/ GM-Tg-bovg-IP2717-Ab-2; GM-Tg-equg-IP2717-Ab-1/ GM-Tg-equg-IP2717-Ab-2
Products NameAnti-RRP7A monoclonal antibody
Formatmab
Target NameRRP7A
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-RRP7A monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2717-Ag-1Recombinant multi-species RRP7A/ BK126B4.3/ CGI-96 protein


    Target information

    Target IDGM-IP2717
    Target NameRRP7A
    Gene ID27341,74778,362967,710471,609569,101085055,512692,100071022
    Gene Symbol and Synonyms1110014J01Rik,BK126B4.3,CGI-96,Kheg1,MCPH28,RGD1311547,Rrp7,RRP7A
    Uniprot AccessionQ9Y3A4
    Uniprot Entry NameRRP7A_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000189306
    Target ClassificationN/A

    The target: RRP7A, gene name: RRP7A, also named as BK126B4.3, CGI-96, Rrp7. Enables RNA binding activity. Predicted to be involved in rRNA processing and ribosomal small subunit assembly. Predicted to act upstream of or within blastocyst formation. Predicted to be located in nucleoplasm. Predicted to be part of CURI complex and UTP-C complex. Implicated in primary autosomal recessive microcephaly. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.